When was Lumenis founded?

Lumenis was founded in 1973 and raised its 1st funding round 33 years after it was founded.

Where is Lumenis located?

Lumenis is headquartered in Yokneam Illit, Israel. It is registered at Slc, Utah.

How many employees does Lumenis have?

As of Jul 31, 2026, the latest employee count at Lumenis is 1413.

Is Lumenis a funded company?

Lumenis is a funded company, having raised a total of $135M across 3 funding rounds to date. The company's 1st funding round was a $***** Series D round, raised on Dec 05, 2006.

When was the latest funding round of Lumenis?

Lumenis' latest funding was a $***** Series D round on Jul 03, 2009, with participation from 2 investors. Its primary sector is Dermatology. Globally, the Dermatology sector has seen $646M in funding in 2026 to date.

Where does Lumenis rank among its competitors?

Lumenis ranks 1st amongst 84 active competitors, of which 4 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Venus, which secured $1.5M in Mar, 2026.

Who are the top competitors of Lumenis?

Lumenis' top competitors include Candela Medical, Venus and Solta. Among them, Venus secured the most recent funding round in March, 2026.

Lumenis - 2026 Company Profile, Funding & Competitors

Q: Is Lumenis an acquired company?

Lumenis got acquired by Boston Scientific on Mar 01, 2021.

Lumenis is an acquired company based in Yokneam Illit (Israel), founded in 1973. It operates as a Minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets. Lumenis has raised $135M in funding. The company has 84 active competitors, including 4 funded and 14 that have exited. Its top competitors include companies like Candela Medical, Venus and Solta.

Company Details

Lumenis develops minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets. In surgical segment their offering includes products for urology, ENT, gynecology and gastroenterology. In aesthetic segment their offering includes hair removal and skin treatments products. In opthalmology segment their offering includes products for glaucoma, retinal diseases. They have presence in over 100 countries. Lumenis was acquired by Viola Group and Ofer Hi-Tech in 2006. XIO acquired Lumenis for $510M in 2015.

Website: lumenis.com
Social
Registered Address: Slc, Utah

Key Metrics

Founded Year

1973

Location

Yokneam Illit, Israel

Stage

Acquired

Total Funding

$135M in 3 rounds

Latest Funding Round

Series D, Jul 03, 2009, $*****

Investors

Goldman Sachs & 7 more

Ranked

1^st among 84 active competitors

Employee Count

1,413 as on Jul 31, 2026

Investment & Acquisitions

WideMed

Similar Companies

Candela Medical & 99 more

Exit Details

Acquired by Boston Scientific (Mar 01, 2021)

View Lumenis' full profile

Lumenis is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LUMENIS BE (INDIA) PRIVATE LIMITED CIN: U51909DL2021PTC383816 , India, Active	Jul 17, 2021	₹10 - ₹50 Cr (As on Mar 31, 2025)	-
LUMENIS INDIA PRIVATE LIMITED CIN: U51900DL2006PTC284625 , India, Active	Mar 01, 2006	0 - ₹10 Cr (As on Mar 31, 2025)	27 (As on Jul 31, 2022)
Lumenis, Inc. CIN: 43155703 , United States, Active	Dec 31, 1999	-	78 (As on Dec 31, 2021)	-

Lumenis got acquired by Boston Scientific on Mar 01, 2021 at an acquisition amount of $*****.

Click here to take a look at Lumenis's acquisition in detail

Lumenis has raised a total funding of $135M over 3 rounds. Its first funding round was on Dec 05, 2006. Its latest funding round was a Series D round on Jul 03, 2009 for $*****. 2 investors participated in its latest round. Lumenis has 8 institutional investors.

Here is the list of recent funding rounds of Lumenis:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 03, 2009	4245162	Series D	3487392	5430715	8146453	2127957
2009	8508	Series D	5012	2942	1801	Agate & 3 more
Dec 05, 2006	1614445	Series D	2146141	6050976	6550335	Ofer-Hi Tech & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Lumenis's funding rounds and investors

Lumenis' employee count trend

Lumenis has 1,413 employees as of Jul 26. Here is Lumenis's employee count trend over the years:

Uncover Lumenis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lumenis include Candela Medical, Venus and Solta. Here is the list of Top 10 competitors of Lumenis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lumenis 1973, Yokneam Illit (Israel), Acquired	Minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets	$135M	Goldman Sachs, Viola Partners & 6 others	63/100
2nd	Candela Medical 1970, Amsterdam (Netherlands), Acquired	Developer of multiple medical device for dermatological health	-	-	57/100
3rd	Venus 2002, Toronto (Canada), Public	Developer of medical aesthetic devices for clinics	$48.7M	Longitude Capital, EW Healthcare Partners ... & 7 others	56/100
4th	Solta 1995, Hayward (United States), Acquired	Range of aesthetic products	-	Foresite Capital, Longitude Capital & 8 others	56/100
5th	Aesthetic Management Partners 1996, Tustin (United States), Unfunded	Medical aesthetics equipment, products, and supplies for optimal skin and hair	-	-	51/100
6th	Cutera 1998, Brisbane (United States), Public	Developer of energy-based medical aesthetic devices for the treatment of multiple diseases	-	Alta Partners, MedVenture Associates	49/100
7th	Spectra Medicals 2005, Chennai (India), Unfunded	Provider of medical and aesthetic equipment, including surgical and non-surgical lasers	-	-	46/100
8th	Wontech 1999, Daejeon (South Korea), Public	Manufacturer of medical laser equipment and ultrasound	-	-	45/100
9th	Cartessa Aesthetics 2017, New York City (United States), Seed	Innovative aesthetic devices maximizing practice potential with cutting-edge technology and treatment options	$60M	PennantPark, Copley Equity Partners	45/100
10th	Wingderm 2016, Beijing (China), Unfunded	Manufacturer of medical and aesthetic devices	-	-	45/100